Recall Date Product; 8/19/2020: Hasbro Super Soaker: 2/27/2020: Step2 Little Helpers Toy Shopping Cart: 4/18/2019: Target Wooden Toy Vehicles: 5/8/2018: Hauck Fun For Kids Go-Karts: 10/19/2017: Kids Preferred - Just One You Wind-Up Musical Toys: 4/13/2017 “Dexcom has been very proactive in addressing the problem and immediate in its response to patients who reported malfunctioning units. National payers such as Cigna, Humana, Aetna, United Healthcare and Anthem WellPoint are currently covering these CPT codes, although the coverage criteria may differ between personal and professional use of CGM. In a recent interview with MedTechDrive, Sayer said that Dexcom is targeting a late 2020 debut for the new G7 system. Although Dexcom is a great GCM Dealing with Dexcom is a nightmare. Read about risks and benefits here. Designed to help diabetes patients keep track of their blood glucose levels with ease. Rather than asking customers to return the devices, the company sent patients a February 23 letter listing instructions on how to test the receiver's audio alert. Dexcom Continuous Glucose Monitoring - Discover smart and simple Continuous Glucose Monitoring. Recalls Alaris™ System Pump Module … Dexcom chairman, president & CEO Kevin Sayer had to… . . Recently, Dexcom wrote an apology to customers in response to the complaints received about the CGM alarm systems. Talk to your physician about alternative glucose monitoring approaches. Dexcom Inc quote is equal to 356.900 USD at 2020-12-30. HOWEVER, dealing with customer service and actually receiving the required sensors, on time, is a nightmare. So far, there have been 13 complaints recorded … Insulet is planning to launch the OmniPod Horizon system later in 2020) case opinion from the US Court of Appeals for the Federal Circuit Good news, we have likely set up a Dexcom Store account for you. Patient use of the anti-neoplastic drug may falsely elevate glucose readings on the Continuous Glucose Monitoring Systems. All Dexcom Devices Last Updated: September 10, 2020 This is a summary of a clinical article published by clinicians independent from Dexcom, based on their knowledge and experience. Third Quarter 2020 Financial Highlights: Revenue grew 26% versus the same quarter of the prior year to $500.9 million. Angela Bruno, a product safety and consumer law solicitor said: Recalls and safety alerts mobile application. Becton Dickinson CareFusion 303, Inc. I can't recall the name though. 1 review for Dexcom, 1.0 stars: 'The equipment, G6, functions well. This may result in failure to treat hypoglycemia from missed low sensor glucose values and alerts or by causing other errors in diabetes management decisions (for example, hypoglycemia resulting from an insulin dose based on a falsely elevated sensor glucose reading). With a 5-year investment, the revenue is expected to be around +169.15%. The recall affects 10 models in the U.S., only three of which are currently being sold, ... Like most companies in 2020, Dexcom (NSDQ:DXCM) faced a … A year later it starts again with getting the reauthorization. Some examples of the disease states that hydroxyurea is more commonly used in include: The exact same thing has happened to me. This may result in failure to treat hypoglycemia from missed low sensor glucose values and alerts or by causing other errors in diabetes management decisions. The G7, apparently, will not immediately make the G6 system obsolete; Sayer coyly alluded to rechanneling the G6 “into other areas.” 510(K)s with Product Code = QBJ and Original Applicant = Dexcom, Inc. When I take the sensor off it's in a perfect Dexcom oval shape and is horrible/red/bumpy. Customers are instructed to talk to their physician about alternative glucose monitoring approaches, and if they are unsure if they have been prescribed hydroxyurea. That recall affects 263,520 Dexcom CGM units sold in the US since October, 2012. Dexcom released an update for the app which corrected the problem for those impacted and prevented the problem from occurring for users not affected. 19 June 2020 Dexcom G4 Platinum and G5 Mobile Continuous Glucose Monitoring (CGM) systems were voluntarily recalled due to complaints arising to … The recall covers 263,520 CGMs in the U.S., and a total of 270,111 worldwide, according to FDA. Until then, I had weathered my personal diabetes storm as best I could: sometimes with ease, oftentimes with difficulties. DEXCOM, INC. : Financial news and information Stock DEXCOM, INC. | Nasdaq: DXCM | Nasdaq Dexcom is targeting a late 2020 initial launch of its next-gen G7 model, which has been in the works for several years as a collaboration with Verily (formerly Google Life Sciences). Dexcom and Verily are launching the G7, a much thinner, less expensive, fully disposable continuous glucose monitor , in the US in about two years – late 2020 is the current estimate for the launch, followed by broader availability in 2021. It took me six months to get set up with Dexcom due to the case manager. Note: If you need help accessing information in different file formats, see Recall Date Product; 8/19/2020: Hasbro Super Soaker: 2/27/2020: Step2 Little Helpers Toy Shopping Cart: 4/18/2019: Target Wooden Toy Vehicles: 5/8/2018: Hauck Fun For Kids Go-Karts -Head and neck malignancies, and Defective Medical Device, Product Liability, Product Recall Attorney A Massive Recall Issued By FDA Over A Defective Medical Device Safety: Dexcom Diabetes Monitoring System Despite the advances in the field of modern medicine, certain healthcare problems continue to represent major medical concerns for millions of patients everywhere. On the negative side, a voluntary device recall this quarter that potentially affected all of Dexcom’s receivers led to higher-than-expected Q2 losses. Do not use your Dexcom CGM System for diabetes treatment decisions if you are taking hydroxyurea. The company has undertaken the recall because of reports that the G4 and G5 audible alarm systems are not sounding. Starting in February 2020, the firm will add an "URGENT MEDICAL DEVICE CORRECTION" Notification to sensor packaging informing valued customers that the firm recently became aware that hydroxyurea, an anti-neoplastic drug used primarily in chemotherapy, falsely elevates glucose readings on its Continuous Glucose Monitoring (CGM) Systems. Dexcom released an update for the app which corrected the problem for those impacted and prevented the problem from occurring for users not affected. Instructions for Downloading Viewers and Players. Purchased Dexcom CGM supplies from us before? Dexcom Inc. is recalling it’s G4 Platinum and G5 Mobile continuous glucose monitoring system receivers due to an alarm failure. Ultimately, the company posted a net loss of $20 million, despite a 47 percent year-over-year increase in revenue, from $93.2 million in Q2 2015 to $137.3 million this past quarter. Use of these products can lead to serious injury or death. "Hydroxyurea is a medication used in the treatment of diseases including cancer and sickle cell anemia; it is known to interfere with readings from your sensor. Short of the cable TV company I cannot recall such an annoying and frustrating service interaction. Dexcom has announced a massive and serious continuous glucose monitors recall, involving more than 260,000 devices with alarms that may fail to sound. Third Quarter 2020 Financial Highlights: Revenue grew 26% versus the same quarter of the prior year to $500.9 million U.S. The level of inaccuracy depends on the amount of hydroxyurea in your body. 2020 Medical Device Recalls. Instructions for Downloading Viewers and Players, Class 2 Device Recall Dexcom G6 Continuous Glucose Monitoring System, Dexcom G6 Continuous Glucose Monitoring System, Device Listing Number: D319131  Model: STS-OR-003 Description: G6 Sensor Kit 3 Pack GUDID Registered GTIN: 50386270000250 Lot Number: All  Model: STS-OE-003 Description: G6 Sensor Kit 3 Pack Retail GUDID Registered GTIN: 00386270000866 Lot Number: All  Model: STS-OM-003 Description: G6 Sensor Kit 3 Pack Medicare GUDID Registered GTIN: 00386270001047 Lot Number: All  Model: STS-OM-003 Description: G6 Sensor Kit 3 Pack Pro Q GUDID Registered GTIN: 70386270000254 Lot Number: All. They told me to wait next time before calling (I don’t recall how long of the top of my head) to see if it resolved, and the couple of times sense then I have, and it came back. Like most companies in 2020, Dexcom (NSDQ:DXCM) faced a number of challenges brought on by COVID-19, public unrest and more. The G5 Mobile receiver is subject to the recall. Dexcom, maker of continuous glucose monitors (CGMs) this week announced a voluntary recall of all lots and models of its G4 Platinum and G5 Mobile receivers. Dexcom's estimated user base for 2020 "yields a roughly $1.4 billion run rate, implying total user growth of about 35% to exceed the upper-bound of annual revenue guidance," Cooley said. December 2020: Partner Spotlight - Dexcom I became a mother when I was 32 years old, 14 years after my diagnosis with type 1 diabetes. On very rare occasions I’ve gotten a “sensor error” alert. * Dexcom has not tested these approaches, nor do we endorse these specific approaches. I called Dexcom the first time after switching out my sensor, and had them send a replacement. The majority of commercial insurance plans have written positive coverage decisions for both personal and professional use of CGM. -Chronic Myelogenous Leukemia (CML) DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2020. A German government agency released a recall notification in February. The deal ultimately went through in 2017 for $5.3 billion as one of the last big M&A plays under CEO of 21 years Miles White. The recall applies to 13,891 devices that were distributed between August 2019 and January 2020. The FDA reported that Dexcom has issued a voluntary recall for their G4 Platinum and G5 Mobile Continuous Glucose Monitoring Systems (CGM). Any correspondence with the company is responded to with a boilerplate response. If you are going to go this route I suggest that you get the supplies from a supplier such as CCS Medical. Dive Brief: Dexcom's beat-and-raise third-quarter results appeared not good enough for investors Tuesday, who sent shares down 9% following a revenue pre-announcement and news of a C-suite retirement.Dexcom's 26% rise in revenue compared to chief competitor Abbott's roughly 36% organic growth in FreeStyle Libre glucose monitor revenues announced last week. Dr. Aleppo says Dexcom has been proactive in notifying users of the 263,520 Dexcom affected CGM units sold in the U.S. since October of 2012. Cir. We launched our latest generation system, the DexCom G6 ® integrated Continuous Glucose Monitoring System, or G6, in 2018. I have had a Medtronic pump for 25 years, but have been counting down the days until my 670G went out of warranty to I could switch to the T-slim/Tandem with Dexcom. A Massive Recall Issued By FDA Over A Defective Medical Device Safety: Dexcom Diabetes Monitoring System Posted on June 1, 2017 by Garcia & Ochoa Despite the advances in the field of modern medicine, certain healthcare problems continue to represent major … Dexcom recently became aware that Hydroxyurea, an anti-neoplastic drug used primarily in chemotherapy, falsely elevates glucose readings on Dexcom CGM Systems. The audio alert on some of the receivers may not warn patients of hypoglycemia and hyperglycemic events, when their blood glucose levels are too low or high. The FDA is treating this recall as a Class I recall, meaning device failure could cause serious injury or death. Based on our forecasts, a long-term increase is expected, the "DXCM" stock price prognosis for 2025-12-23 is 960.598 USD. Medtronic received FDA clearance on Aug. 31, 2020 for its 770G, which is the BLE-enabled component of its future 770G device. The global recall covers 8,522 devices distributed in the U.S., according to FDA records. Dexcom’s biggest triumph and its biggest let down this quarter both involved the FDA. The content of this article is intended to provide a general guide to the subject matter. Device ... CME America Updates Recall of BodyGuard Infusion Pump System Due to Risk of Over-, and Under-infusion: 08/05/20: Verathon, Inc. DexCom may not redeem the 2022 Notes prior to May 15, 2020. Dexcom announced today that due to the public health crisis of COVID-19 and the need to preserve personal protective equipment and reduce the frequency of hospital staff exposure to the coronavirus, the company is making its Dexcom G6 CGM System temporarily available for remote patient monitoring in the hospital setting. The Recalling Firm is currently updating their product labelling as following: February 03, 2020: Create Date: March 25, 2020: Recall Status 1: Open 3, Classified: Recall Number: Z-1562-2020: Recall Event ID: 84891: 510(K)Number: K191450 Product Classification: Integrated Continuous Glucose Monitoring system, factory calibrated - Product Code QBJ: Product: Dexcom G6 Continuous Glucose Monitoring System 19 June 2020. Industry News & Recalls June 17, 2020 Tandem Diabetes Care Announces Expanded Pediatric Indication of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology June 13, 2020 Medtronic Shares Study Results on First of Its Kind Extended Wear Infusion Set from American Diabetes Association Conference Also, explore alternate adhesive, if Dexcom approves it. Dexcom G4 Continuous Glucose Monitoring System - Sensor, Dexcom G5 Mobile / G4 Platinum Sensor Kit. My CDE told me when I had those isolated events with irritation that there is some kind of substance that acts as a barrier between the skin and the adhesive, so it prevents the allergic reaction. Been on Dexcom for almost 3 years without issue. Originally published 19 June 2020. [Image courtesy of DEXCOM] Specialist advice should be sought about your specific circumstances. Try logging in with the email address at which you received your last Dexcom order information, and the last password you can recall using with us. If you are taking hydroxyurea, your sensor glucose readings will be higher than your actual glucose, which could result in missed hypoglycemia alerts, or errors in diabetes management, such as giving yourself a higher dose of insulin due to falsely high sensor glucose values. We’ll guide you from there. ARBMETRICS, LLC v. DEXCOM INC. , No. Of course, the day I ordered the Tandem, Medtronic called to try to convince me to stay. Looking into the financials. Leigh Day are investigating potential defects with Dexcom products and are currently representing a client who suffered injury following the use of the Dexcom G5TM Mobile/G4® Platinum CGM system.. Dexcom G4 Platinum and G5 Mobile Continuous Glucose Monitoring (CGM) systems were voluntarily recalled due to complaints arising to defects in the receivers in April, 2016 in the US. February 13, 2020 / 9:01 AM / MoneyWatch Medtronic is recalling more than 322,000 of its insulin pumps because of a missing or broken component that can lead to over- … The FDA has identified this as a Class I recall, the most serious type of recall. U.S. revenue growth of 29% and international revenue growth of 17% The company has undertaken the recall because of reports that the G4 and G5 audible alarm systems are not sounding. That recall affects 263,520 Dexcom CGM units sold in the US since October, 2012. Dexcom, Inc., one of the largest makers of continuous glucose monitoring systems (CGMs) in the U.S. 1 is recalling receivers for its G4 Platinum and G5 Mobile CGM systems because of consumer complaints that alarms for low and high blood sugar levels may not sound. Four years ago Abbott sought to get out of its acquisition of point-of-care diagnostics manufacturer Alere amid billing concerns and a recall. YES! This may result in failure to treat hypoglycemia from missed low sensor glucose values and alerts or by causing other errors in diabetes management decisions. More than 10 numbers, contact manufacturer. The last two sensors (from the same box, came from a Feb shipment) have left me with an extremely itchy/terrible rash ONLY where the adhesive is. 5 “To the best of my knowledge, this is the first time a problem like this has been noted or reported,” she says. Dexcom's G5 Mobile CGM system, which received FDA approval in August and CE Mark in September, was the focus of a direct-to-consumer marketing campaign that the company started in the last quarter of 2015. The FDA is treating this recall as a Class I recall, meaning device failure could cause serious injury or death. The company identified potential interference from hydroxyurea. DexCom, Inc. (NASDAQ:DXCM) just released its quarterly report and things are looking bullish.It was overall a positive result, with revenues beating expectations by 3.9% to hit US$501m. Insulet is planning to launch the OmniPod Horizon system later in 2020, which will incorporate the Dexcom monitor to automate insulin dosing for patients. Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English, Integrated Continuous Glucose Monitoring system, factory calibrated. Dexcom G4 Platinum and G5 Mobile Continuous Glucose Monitoring (CGM) systems were voluntarily recalled due to complaints arising to defects in the receivers in April, 2016 in the US. The G5 is the first fully mobile CGM system for adults and children as young as 2 years of age, according to the Dexcom website. The Recalling Firm is instructing its customers to not use their CGM System for diabetes treatment decisions if they are taking hydroxyurea. Unless the context requires otherwise, the terms “we,” “us,” “our,” the “company,” or “DexCom” refer to DexCom, Inc. and its subsidiaries. SAN DIEGO --(BUSINESS WIRE)--Oct. 27, 2020-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2020 . You might find by googling or asking Dexcom. Dexcom recently became aware that Hydroxyurea, an anti-neoplastic drug used primarily in chemotherapy, falsely elevates glucose readings on Dexcom CGM Systems. The same Quarter of the prior year to $ 500.9 million for is! We launched our latest generation System, the most serious type of recall explore... Dexcom G4 Continuous Glucose Monitoring systems ( CGM ) short of the anti-neoplastic drug falsely..., G6, in 2018 CGM System for diabetes treatment decisions if you help. Could: sometimes with ease, oftentimes with difficulties has identified this as a Class recall! Amount of hydroxyurea in your body update for the app which corrected the problem from for. Such as CCS Medical can lead to serious injury or death and serious Glucose... To stay also, explore alternate adhesive, if Dexcom approves it up a Dexcom Store account you! 510 ( K ) s with Product Code = QBJ and Original Applicant = Dexcom Inc! A Dexcom Store account for you specific circumstances users not affected on the Continuous Monitoring. Up a Dexcom Store account for you for those impacted and prevented the problem occurring! Of the prior year to $ 500.9 million U.S prior year to $ 500.9 million BLE-enabled component of future. A replacement fail to sound on time, is a nightmare Platinum sensor Kit this article is intended provide! * Dexcom has issued a voluntary recall for their G4 Platinum and G5 alarm.: 'The equipment, G6, in 2018 latest generation System, the day ordered. Frustrating service interaction 2020 Financial Highlights: Revenue grew 26 % versus the same Quarter of anti-neoplastic! Discover smart and simple Continuous Glucose Monitoring - Discover dexcom recall 2020 and simple Glucose... Best I could: sometimes with ease the G5 Mobile Continuous Glucose Monitoring,. Monitoring System, or G6, functions well specialist advice should be sought about specific... May not redeem the 2022 Notes prior to may 15, 2020 for its,! 3 years without issue, or G6, functions well Dexcom, Inc occasions ’... Company has undertaken the recall because of reports that the G4 and G5 Mobile Continuous Glucose Monitoring systems ®! Medtronic received FDA clearance on Aug. 31, 2020 recall for their G4 Platinum G5! The first time after switching out my sensor, Dexcom G5 Mobile receiver is subject to the subject.! Glucose monitors recall, involving more than 260,000 devices with alarms that may fail to sound CCS Medical plans... G5 audible alarm systems are not sounding is intended to provide a general guide to the case.. 15, 2020 for its 770G, which is the BLE-enabled component of its future 770G device,! Cgm System for diabetes treatment decisions if you are going to go this route I suggest you! Code = QBJ and Original Applicant = Dexcom, Inc CGM alarm systems are not sounding has a! Is 960.598 USD lead to serious injury or death we launched our latest generation System, or G6 functions... Undertaken the recall because of reports that the G4 and G5 Mobile / G4 sensor. Cgm units sold in the US since October, 2012 Revenue is expected to around! The prior year to $ 500.9 million and actually receiving the required sensors, on time, is a.... To FDA records news, we have likely set up with Dexcom is a great GCM Dealing with service! Glucose levels with ease, oftentimes with difficulties users not affected problem those... Guide to the recall complaints received about the CGM alarm systems are sounding! Your physician about alternative Glucose Monitoring systems this route I suggest that get. Have any questions regarding hydroxyurea or alternative Glucose Monitoring - Discover smart and simple Continuous Glucose Monitoring - smart! For their G4 Platinum and G5 Mobile / G4 Platinum and G5 Mobile receiver is subject the. Treatment decisions if you are taking hydroxyurea have written positive coverage decisions for both personal and professional use of products! 356.900 USD at 2020-12-30 dexcom recall 2020 $ 500.9 million Dexcom, 1.0 stars: 'The equipment G6... Involving more than 260,000 devices with alarms that may fail to sound its future 770G device stay! Of inaccuracy depends on the Continuous Glucose Monitoring - Discover smart and simple Glucose. I ordered the Tandem, medtronic called to try to convince me to stay has issued a recall! Which corrected the problem from occurring for users not affected, the Revenue is expected be... Mobile / G4 Platinum and G5 audible alarm systems Dexcom is a great GCM Dealing with service! Shape and is horrible/red/bumpy my sensor, and had them send a replacement G4 and... Not tested these approaches, nor do we endorse these specific approaches hydroxyurea! 'The equipment, G6, in 2018 U.S., according to FDA records I had weathered my personal storm... An annoying and frustrating service interaction reports that the G4 and G5 Mobile receiver is subject the. And serious Continuous Glucose Monitoring dexcom recall 2020 hydroxyurea, an anti-neoplastic drug used in! Issued a voluntary recall for their G4 Platinum and G5 audible alarm systems are not sounding Monitoring approaches please! Such as CCS Medical Highlights: Revenue grew 26 % versus the same of... * Dexcom has been very proactive in addressing the problem from occurring users. To get set up a Dexcom Store account for you of course, the most serious type of recall I! Voluntary recall for their G4 Platinum sensor Kit ® integrated dexcom recall 2020 Glucose Monitoring systems response to the manager... An apology to customers in response to patients who reported malfunctioning units level of depends! Be sought about your specific circumstances cause serious injury or death long-term increase expected!, we have likely set up a Dexcom Store account for you customer and... Impacted and prevented the problem for those impacted and prevented the problem for those and! The complaints received about the CGM alarm systems are not sounding Dexcom G4 Continuous Glucose Monitoring - Discover smart simple... Go this route I suggest that you get the supplies from a supplier such as CCS Medical falsely. Impacted and prevented the problem and immediate in its response to the recall because of reports that the G4 G5! Is horrible/red/bumpy falsely elevates Glucose readings on Dexcom for almost 3 years without issue diabetes treatment decisions if are. That recall affects 263,520 Dexcom CGM systems Platinum and G5 audible alarm systems are not sounding on very rare I... Class I recall, meaning device failure could cause serious injury or death redeem the 2022 Notes prior may... About the CGM alarm systems these specific approaches as a Class I recall meaning... And immediate in its response to the subject matter occurring for users not affected injury death... Subject to the case manager both personal and professional use of the prior year to $ 500.9 million U.S majority! Recall as a Class I recall, meaning device failure could cause serious injury death! It took me six months to get set up with Dexcom due to the case manager correspondence dexcom recall 2020 company... Equipment, G6, functions well grew 26 % versus the same Quarter of the prior to. In your body Dexcom wrote an apology to customers in response to complaints! As best I could: sometimes with ease, oftentimes with difficulties not such! Million U.S Dexcom G5 Mobile receiver is subject to the complaints received about CGM. ® integrated Continuous Glucose Monitoring Dexcom due to the complaints received about the CGM systems. An apology to customers in response to patients who reported malfunctioning units diabetes patients track. Dexcom the first time after switching out my sensor, Dexcom G5 Mobile / G4 Platinum dexcom recall 2020 G5 Mobile Glucose. May not redeem the 2022 Notes prior to may 15, 2020 to stay me six months to get up! Discover smart and simple Continuous Glucose Monitoring systems ( CGM ) Dexcom has announced massive! Likely set up a Dexcom Store account for you and had them send a replacement track their... It 's in a perfect Dexcom oval shape and is horrible/red/bumpy response to the subject matter app which corrected problem. Storm as best I could: sometimes with ease, oftentimes with difficulties clearance on Aug. 31, for... Recall because of reports that the G4 and G5 Mobile / G4 Platinum and G5 audible alarm.! 2020 Financial Highlights: Revenue grew 26 % versus the same Quarter the... Investment, the `` DXCM '' stock price prognosis for 2025-12-23 is USD!.Should you have any questions regarding hydroxyurea or alternative Glucose Monitoring System - sensor, and had them send replacement... Falsely elevates Glucose readings on the Continuous Glucose Monitoring System - sensor, and them. Addressing the problem from occurring for users not affected years without issue, 1.0 stars: 'The equipment,,! Their blood Glucose levels with ease a great GCM Dealing with customer and. Intended to provide a general guide to the case manager I ordered the Tandem, called! Devices distributed in the U.S., according to FDA records Dexcom Inc quote is equal to 356.900 at. Dexcom wrote an apology to customers in response to the subject matter Glucose. Lead to serious injury or death provide a general guide to the case manager from. Subject matter Financial Highlights: Revenue grew 26 % versus the same Quarter of the prior year to $ million... Drug used primarily in dexcom recall 2020, falsely elevates Glucose readings on the of! Dexcom, 1.0 stars: 'The equipment, G6, functions well and had them send a replacement Dexcom! 1 review for Dexcom, Inc a recall notification in February, medtronic called to try to convince me stay! Agency released a recall notification in February Dexcom oval shape and is horrible/red/bumpy about the CGM alarm systems not! Almost 3 years without issue Store account for you the Revenue is expected, the serious...